Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in middle-aged men

Charles J. Tanner1,2, Timothy R. Koves3, Ronald L. Cortright1,2,3, Walter J. Pories3, Young-Bum Kim4, Barbara B. Kahn4, G. Lynis Dohm1,3, and Joseph A. Houmard1,2

1 Human Performance Laboratory, Diabetes/Obesity Center, and 2 Departments of Exercise and Sport Science, and 3 Biochemistry, Medicine, Physiology, and Surgery, East Carolina University, Greenville, North Carolina 27858; and 4 Diabetes Unit, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

The purpose of this study was to determine whether the improved insulin action with short-term exercise training in middle-aged individuals is associated with enhanced phosphatidylinositol (PI) 3-kinase activity in skeletal muscle. Nine men of ages 50-70 yr were studied before and after 7 consecutive days of supervised exercise (60 min/day, 70% peak O2 consumption). Insulin sensitivity was measured with a euglycemic hyperinsulinemic glucose clamp in the sedentary condition and 15-17 h after the final exercise session. Anti-phosphotyrosine-associated PI 3-kinase activity was determined from muscle samples obtained in the fasted condition and after 60 min of insulin infusion during the clamp. With exercise, the glucose infusion rate increased (P < 0.001) by 33%, indicating enhanced insulin action (mean ± SE, 6.6 ± 0.6 vs. 8.7 ± 0.8 mg · kg-1 · min-1). Short-term exercise training did not, however, increase insulin-stimulated (insulin stimulated/fasting) PI 3-kinase activity (1.8 ± 0.8 vs. 1.8 ± 0.7-fold stimulation with insulin pre- vs. posttraining, respectively). There was also no change in insulin-stimulated protein kinase B activity (1.3 ± 0.1 vs. 1.4 ± 0.2-fold stimulation with insulin) with training. These data suggest that insulin action is enhanced with short-term exercise training via an adaptation distal to PI 3-kinase in middle-aged, insulin-resistant individuals.

aging; glucose transport; insulin resistance; physical activity; skeletal muscle


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

EXERCISE TRAINING improves insulin action in middle- to older-aged individuals (7, 8, 18, 33). This effect occurs relatively rapidly, with enhanced insulin action evident after as little as seven consecutive days of physical activity [50-60 min/day at 50-75% peak oxygen consumption (VO2 peak)] (7, 8, 33). The ability to improve insulin action with exercise in an older population is important, because the insulin resistance of aging begins early in middle age (30-40 yr) and is associated with an enhanced risk for coronary artery disease, obesity, and type 2 diabetes (11, 13, 20, 31).

Although exercise improves insulin action in middle- to older-aged subjects, the cellular mechanisms involved are not yet evident. Recent findings have increased our understanding of the cellular events leading to insulin-stimulated glucose transport (for reviews see Refs. 10, 22, 34). Briefly, the process is initiated with ligand binding to the insulin receptor and tyrosine kinase activation that leads to phosphorylation and activation of a family of insulin receptor substrates (IRS). The subsequent docking of phosphatidylinositol (PI) 3-kinase to an IRS results in phosphorylated lipid products, which activate yet-undefined downstream signaling pathways (36). This signaling process ultimately induces translocation of the insulin-sensitive glucose transporter (GLUT-4) to skeletal muscle membranes and facilitates sugar transport into the cell (10, 21, 34, 36). After 7 days of exercise training, GLUT-4 and insulin action increased by the same relative magnitude in young and middle-aged subjects (8), indicating that older individuals retain the ability to respond to the exercise stimulus.

The effect of exercise training on the signaling events that induce GLUT-4 translocation are not, however, evident, particularly in aged skeletal muscle (16). Several studies have focused on PI 3-kinase, as this protein is directly involved in insulin-mediated glucose transport (10, 35, 36, 37). In young subjects, exercise training increased insulin-stimulated PI 3-kinase activity in conjunction with insulin action (19, 26). However, Cusi et al. (9) reported no improvement in insulin-stimulated PI 3-kinase activity in obese individuals and type 2 diabetics after a single exercise bout; insulin action was also not enhanced. This finding (9) suggests that the insulin-signaling pathway may also be resistant to the exercise training stimulus (i.e., consecutive days of exercise as opposed to a single exercise bout; Ref. 9) at the level of PI 3-kinase in insulin-resistant individuals. The effect of exercise training that improves insulin action on PI 3-kinase has not, however, been studied in an older insulin-resistant population. The purpose of the current study was, therefore, to examine the effect of a short-term exercise training protocol demonstrated to improve insulin action (8) on insulin-mediated PI 3-kinase activity in middle-aged subjects. Due to our previous finding of enhanced PI 3-kinase in young subjects with physical activity (19), our hypothesis was that insulin-stimulated PI 3-kinase activity in skeletal muscle from middle-aged individuals would increase with exercise training, in conjunction with improved insulin action.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Study design. Subjects were assessed for suitability by an interview, health history questionnaire, and medical clearance. Preliminary assessments included body composition and a VO2 peak test 1) to ensure that subjects were sedentary, 2) to ensure that there was no overt evidence of heart disease, and 3) to calculate the workload used during exercise training. After these preliminary measurements, a pretraining hyperinsulinemic euglycemic clamp was administered with muscle biopsies performed before and 60 min into the clamp. A period of 7 consecutive days of exercise training (cycle ergometer) was initiated within 14 days of the clamp. Fifteen to seventeen hours after the last training bout, a posttraining hyperinsulinemic euglycemic clamp was administered, and muscle biopsies were performed before and 60 min into the clamp. PI 3-kinase activity was determined in all of the muscle samples, as this was the primary focus of the study. There was sufficient material remaining in four subjects to determine protein kinase B (Akt) activity.

Subjects. All subjects read and provided informed consent to acknowledge the risks and procedures involved before participating in this study. Approval by the East Carolina University Policy and Review Committee on Human Research was obtained before any testing was performed. Nine untrained, middle-aged (50-70 yr) Caucasian men were recruited as volunteers. Subjects exhibited no evidence of cardiovascular disease, were not taking medications that could affect carbohydrate metabolism or exercise tolerance, and did not have orthopedic difficulties that could hinder exercising. Subjects had not performed regular exercise for at least 2 yr before initiation of the study.

VO2 peak was determined using a Lode electronically braked cycle ergometer (Diversified, Brea, CA) during an incremental exercise test to voluntary exhaustion. Each subject was monitored with a 12-lead electrocardiogram in the presence of a physician. Heart rate was calculated for the final minute of every 3-min stage. Subjects were asked to exercise to exhaustion and until at least two of the following criteria for a valid test was obtained: a leveling of VO2 with increasing workload; respiratory exchange ratio >1.1; and a maximal heart rate <= 15 beats of age-predicted maximal heart rate.

Body composition. Subjects were initially measured for height and mass. Mass was also measured before each training bout to ensure minimal alterations over the 7-day period. Subjects were instructed to consume an additional 300-400 kcal/day to offset the energy expended during exercise but not to alter any other aspects of diet. To characterize the health and obesity status of the subjects, body composition was initially estimated using the seven-site skinfold equation (21).

Hyperinsulinemic euglycemic glucose clamp. The procedures used during the clamp have been summarized elsewhere (17, 19) and were a modification of the method developed by DeFronzo et al. (12). Briefly, arterialized blood was drawn from a heated hand vein to determine glucose and insulin levels. After determination of baseline glucose concentration, a primed continuous infusion of insulin (100 mU · m-2 · min-1) was started. We previously developed a time course for the PI 3-kinase response to this insulin dosage in human skeletal muscle (17), and we have reported an increase in insulin action and PI 3-kinase activity after short-term exercise training with this technique (19). Plasma glucose concentration was determined every 5 min throughout the test (2300 STATplus, Yellow Springs Instrument, Yellow Springs, OH), and adjustments were made, as necessary, in the rate of glucose infusion (M-value) to maintain euglycemia at fasting basal levels. Plasma for insulin concentration was obtained every 10 min and stored at -80°C. The clamp was performed for 120 min. A microparticle enzyme immunoassay was used for the subsequent measurement of plasma insulin with an Abbott IMx analyzer (Abbott Laboratories, Abbott Park, IL). A steady-state M-value was determined from the final 30 min of the clamp (12).

Exercise training. All exercise training was performed in the laboratory under the supervision of an exercise physiologist (C. J. Tanner). Training duration was 60 min/session; frequency was 1 session/day for 7 consecutive days. Exercise intensity was maintained at 70% of the subject's VO2 peak by analysis of expired gases every 5-15 min. Heart rate was continuously recorded using a Polar heart rate monitor (Polar USA, Stamford, CT) to ensure an adequate training intensity. This exercise program has been used previously in this laboratory (8, 19) and by others (7, 33) to improve insulin action without weight loss in insulin-resistant individuals.

Muscle biopsy. Muscle samples of ~60 mg were obtained from the lateral portion of the vastus lateralis, before training and 15-17 h after the last training bout for the determination of PI 3-kinase and Akt activity. Before initiation of the clamp, a biopsy was obtained from the left leg as the basal, fasting sample. The second biopsy was obtained from the right leg after 60 min of insulin exposure. The same sequence was performed after the 7 days of training. Tissue was obtained 60 min into the clamp, as we have previously demonstrated optimal PI 3-kinase activation at this time point with the insulin dosage and clamp procedure used in the present study (17). Other studies (2, 40, 41) have also obtained muscle biopsies at similar time points (40-100 min) during a glucose clamp when measuring insulin-signaling events.

PI 3-kinase assay. PI 3-kinase activity was assayed after immunoprecipitation with an anti-phosphotyrosine antibody according to methods previously used in this (17, 19) and other (14, 15) laboratories. Skeletal muscle from the biopsies was homogenized in ice-cold buffer (1:10 wt/vol) containing 1% (vol) Nonidet P-40 for 30 s. The supernatant was incubated overnight at 4°C with anti-phosphotyrosine conjugated to agarose beads (Sigma A-1806). Labeled lipids were extracted with 300 µl of methanol-chloroform (1:1, vol/vol), reaction products were visualized on a phosphorimager, and radioactivity was quantified by densitometry. Results were normalized to protein content.

Akt assay. Akt activity was determined as previously described (23, 24). Twenty milligrams of muscle were homogenized using a polytron at one-half maximum speed for 1 min on ice in 500 ml of buffer A (in mM: 20 Tris, pH 7.5, 5 EDTA, 10 Na4P2O7, 100 NaF, 2 Na3VO4) containing 1% NP-40, 1 mM phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, and 10 mg/ml leupeptin. Tissue lysates were solubilized by continuous stirring for 1 h at 4°C and centrifuged for 10 min at 14,000 g. Muscle lysates (200 mg protein) were subjected to immunoprecipitation for 4 h at 4°C with 3 mg of Akt antibody, which recognizes both Akt1 and Akt2 (Upstate Biotechnology, Lake Placid, NY) coupled to protein G-Sepharose beads (Pharmarcia Biotech, Piscataway, NJ). Immune pellets were washed, and Akt activity was determined as previously described (24, 25).

Statistical analysis. PI 3-kinase activity was expressed as degree of stimulation over fasting by dividing the measured activity after 60 min of insulin exposure by the fasting activity. Repeated-measures analysis of variance (ANOVA) on log-normalized and non-log-normalized data was used to test for a difference between insulin stimulation before and after short-term exercise training. All other variables were compared with repeated-measures ANOVA. Statistical significance was denoted at the P < 0.05 level, and data are presented as means ± SE.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Subjects. Physical characteristics of the subjects are presented in Table 1. The exercise characteristics of the subjects are presented in Table 2. Subjects exercised at ~70% of VO2 peak during the training sessions. Total body weight, which was measured each day immediately before exercise, was not significantly altered during the 7 days of training (P = 0.49).

                              
View this table:
[in this window]
[in a new window]
 
Table 1.   Selected subject characteristics (n = 9)


                              
View this table:
[in this window]
[in a new window]
 
Table 2.   Characteristics during maximal exercise and 7 days of exercise training (n = 9)

Insulin action. Fasting plasma insulin concentration tended to decrease with the 7 days of training (8.8 ± 1.4 vs. 6.8 ± 1.4 µU/ml for pre- vs. posttraining, respectively, P = 0.10). Fasting plasma glucose concentration also tended to decrease with physical activity (100.4 ± 5.1 vs. 97.0 ± 4.9 mg/dl, P = 0.09). There were no significant differences (P = 0.38) in insulin or glucose concentration during the final 30 min of the clamp for before vs. after short-term exercise training (Fig. 1).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 1.   Plasma glucose (triangles) and insulin (squares) concentrations during the euglycemic hyperinsulinemic glucose clamp before (open symbols) and after (closed symbols) 7 days of exercise training (n = 9).

M-values were used as the index of insulin action (11). Mean M-value before training was 6.6 ± 0.6 vs. 8.7 ± 0.8 mg · kg-1 · min-1 after training. This represented a 33% mean improvement in insulin action (P < 0.001, Fig. 2).


View larger version (10K):
[in this window]
[in a new window]
 
Fig. 2.   Insulin action (M-value) before and after 7 days of training at ~70% peak O2 consumption in middle-aged (58 yr) men (black-triangle, n = 9). *Significantly different (P < 0.0001) between pre- and posttraining.

PI 3-kinase activity. Insulin-stimulated PI 3-kinase activity was expressed as mean degree of stimulation over fasting activity and is depicted before and after the 7 days of exercise training in Fig. 3. Mean insulin-stimulated PI 3-kinase activity did not change (1.8 ± 0.8 vs. 1.8 ± 0.7 mean degree of change over fasting for pre- vs. posttraining, respectively; P = 0.63) with short-term training (Fig. 3). These degrees of increase in PI 3-kinase activity with insulin were within the ranges reported in other studies examining the skeletal muscle of insulin-resistant humans during a glucose clamp [range 0-1.5 degree of stimulation over fasting with insulin exposure (2, 9, 24, 28)]. Before the 7 days of exercise training, insulin-stimulated anti-phosphotyrosine-associated PI 3-kinase activity was not statistically different (P = 0.93) from fasting PI 3-kinase activity (45.0 ± 16.0 vs. 67.9 ± 19.9 arbitrary units for fasting vs. insulin-stimulated activity, respectively). After training, insulin again did not significantly increase (P = 0.96) anti-phosphotyrosine-associated PI-3 kinase activity over fasting activity (46.7 ± 13.9 vs. 67.1 ± 21.0 arbitrary units for fasting vs. insulin-stimulated activity, respectively). These data are in agreement with findings obtained in other in vivo studies of insulin-resistant subjects (2, 9, 24), where insulin did not significantly increase PI 3-kinase activity over fasting activity in skeletal muscle.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 3.   Mean insulin-stimulated phosphatidylinositol (PI) 3-kinase activity (insulin stimulated/fasting activity) before and after 7 days of exercise training in middle-aged men (n = 9).

Akt activity. As presented in Fig. 4, insulin-stimulated Akt activity did not change with exercise training. Insulin infusion during the clamp enhanced Akt activity a mean of 1.3 ± 0.1-fold before exercise training and a mean of 1.4 ± 0.2-fold after training; these values were not significantly different (P = 0.61). To our knowledge, there are no insulin-stimulated Akt data in insulin-resistant human muscle for the purpose of comparison. Insulin did not increase Akt activity compared with fasting before training (2,357 ± 74 vs. 2,573 ± 112 arbitrary units for fasting vs. insulin stimulated, respectively; P = 0.18). However, after training, insulin exposure did increase Akt activity compared with fasting (2,145 ± 158 vs. 2,704 ± 82 arbitrary units for fasting vs. insulin stimulated, respectively; P = 0.04).


View larger version (13K):
[in this window]
[in a new window]
 
Fig. 4.   Mean insulin-stimulated protein kinase B (Akt) activity (insulin stimulated/fasting activity) before and after 7 days of exercise training in middle-aged men (n = 4).


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

PI 3-kinase is an important regulatory step of insulin signal transduction in insulin-sensitive cells (36, 37). Studies utilizing various biochemical techniques and pharmaceutical agents have demonstrated that PI 3-kinase is a necessary component of insulin-mediated glucose transport (35-37). Thus, although the signaling components downstream of PI 3-kinase are not well characterized, a specific role for PI 3-kinase in insulin-stimulated glucose transport is apparent (35-37).

In previous work from our laboratory (19), an identical 7-day exercise training program increased insulin-stimulated PI 3-kinase activity about threefold compared with the nonexercising, sedentary condition in the skeletal muscle of young individuals (25 yr) in concordance with improved insulin action. In a cross-sectional design, Kirwan et al. (26) recently reported that insulin-stimulated IRS-1-associated PI 3-kinase activity was at least doubled in the skeletal muscle of young (mean age of 24 yr), endurance-trained subjects compared with their sedentary counterparts. In rodents, enhanced PI 3-kinase activity with insulin stimulation was reported after 1 and 5 days of exercise training (6). In contrast to these data, the main finding of the present study was that insulin-stimulated PI 3-kinase activity did not increase with short-term exercise training in the skeletal muscle of middle-aged men (Fig. 3). This result suggests that the insulin-signaling cascade, at least at the level of PI 3-kinase, may respond differently to the exercise training stimulus, depending upon the population examined.

The differing response of insulin-stimulated PI 3-kinase activity to exercise training in young (19, 26) vs. older individuals (Fig. 3) may involve obesity status and the initial presence of insulin resistance. It has been reported that aging (5), obesity (9, 15, 25), and type 2 diabetes (2, 9, 24) dramatically decrease the responsiveness of PI 3-kinase to insulin. For example, Carvalho et al. (5) reported an ~90% decline in insulin-stimulated PI 3-kinase activity in skeletal muscle from young (2 mo) vs. aged (20 mo) male Wistar rats. In type 2 diabetic and obese subjects, insulin-stimulated anti-phosphotyrosine-associated PI 3-kinase activity in skeletal muscle is virtually abolished (2, 9), as was the case in the present study (RESULTS, Fig. 3). A marked inability to activate PI 3-kinase with insulin is thus displayed in conditions typically associated with insulin resistance.

In an attempt to overcome this resistance in activation of PI 3-kinase, Cusi et al. (9) subjected obese subjects or individuals with type 2 diabetes to a single, relatively mild (60 min, 65% VO2 max) exercise bout and studied components of the insulin-signaling pathway 24 h after the exercise session. In these insulin-resistant individuals, a single exercise bout did not increase either insulin-stimulated IRS-1 or phosphotyrosine-associated PI 3-kinase activity, nor did it enhance insulin action compared with preexercise values (9). Phosphorylation of the insulin receptor and IRS-1 along with glycogen synthase activity did, however, increase. These authors (9) concluded that a single bout of exercise could not overcome the defect in the insulin-signaling pathway present with insulin resistance and that PI 3-kinase defines a key step in the insulin-resistant state. The current data provide the important additional information that insulin signal transduction at the level of PI 3-kinase is not altered with the more robust intervention of short-term exercise training that improves insulin action in insulin-resistant subjects (Figs. 2 and 3). This novel finding suggests that adaptations downstream of PI 3-kinase or alternate insulin-signaling pathways may be responsible for the improvement in insulin action with physical activity in middle-aged, insulin-resistant subjects.

To examine other potential mechanisms, we measured the activity of an additional insulin-signaling element. Akt is hypothesized to be the next step distal to PI 3-kinase in the insulin-signaling process for glucose transport (4, 27). Insulin-stimulated Akt activity can also be reduced in the insulin-resistant state (24, 28). In agreement with our PI 3-kinase data, we observed no increase in the activation of Akt with insulin after training (Fig. 4). It must be considered, however, that the Akt data were obtained in a small subset of subjects and that exercise may have different effects on the individual isoforms of Akt.

Because the magnitude of the insulin signal did not appear to change, another factor may be responsible for the improvement in insulin action with training (Fig. 2). Systemic factors such as increased muscle blood flow with training may enhance insulin-mediated glucose uptake (1). In relation to skeletal muscle, the overexpression of GLUT-4 in transgenic mice produces an approximately twofold increase in protein concentration, which is similar in scope to the exercise training response (8, 16, 18, 29, 32, 38, 39). In these transgenic animals, insulin sensitivity is enhanced. It was suggested (3) that, in obese Zucker rats, the increase in GLUT-4 with training alone compensated for the defect in insulin-stimulated GLUT-4 translocation. These data suggest that the presence of additional insulin-sensitive glucose transporters in skeletal muscle with exercise training may be sufficient to enhance whole body insulin action without an accompanying amplification of the insulin-signaling process. In support of this hypothesis, in previous work from our laboratory (8), GLUT-4 concentration increased approximately twofold in conjunction with enhanced insulin action after an identical 7-day exercise training program in similar middle-aged men. This finding (8) suggests that GLUT-4 increased to a extent similar to that in the current study, although we did not measure the concentration of this protein again.

It must be acknowledged that some aspect(s) of the insulin-signaling cascade may also have been overlooked with the current experimental design. For example, a yet-unidentified signaling step distal to PI 3-kinase or Akt could be enhanced with exercise, as well as an alternative insulin-signaling system. Also, in the present study, total PI 3-kinase activity was determined after immunoprecipitation with a phosphotyrosine antibody. This approach was used because it measures ~95% of the activated PI 3-kinase (30); we have also observed a relationship between total PI 3-kinase activity and insulin-mediated glucose uptake in humans (17). It is possible that IRS-1- or IRS-2-associated PI 3-kinase activity may have been differentially affected with training (6). There are also seven insulin-regulated PI 3-kinase isoforms, which may exhibit separate responses to training (23, 35). It must be considered, however, that phosphotyrosine-associated PI 3-kinase activation was enhanced after 7 days of training in young individuals with the use of identical methods in our laboratory (19). It is thus logical to assume that the methodology used would have detected an increase in PI 3-kinase activity with exercise.

Exercise training improves insulin action through both acute effects from the last training bout and the chronic accumulation of successive exercise sessions (16). The current experiment was not designed to distinguish between acute and chronic influences of physical activity on insulin action. Rather, we utilized the 7-day model because it has been demonstrated to enhance insulin action in insulin-resistant subjects without a confounding change in body mass (7, 8, 33; RESULTS). An interesting finding was that exercise improved insulin action by the same relative magnitude (~30%) in both young and middle-aged subjects when we compared the current findings with previous data from our laboratory (19). This finding indicates that middle-aged individuals maintain the ability to adapt to an exercise stimulus and improve insulin action. The cellular mechanism(s) involved still, however, remains largely undefined.

In summary, a 7-day exercise training program significantly improved insulin action in insulin-resistant, middle-aged men. The improvement in insulin action with exercise was not accompanied by enhanced insulin signal transduction at the level of PI 3-kinase or Akt in skeletal muscle. These data suggest that short-term exercise training enhances insulin action in middle-aged individuals via an adaptation distal to PI 3-kinase.


    ACKNOWLEDGEMENTS

Special thanks to the Diabetes/Obesity Center at the Brody School of Medicine and Pitt County Community Hospital for providing the use of their facilities.


    FOOTNOTES

This research was supported by grants from the American College of Sports Medicine Foundation (J. A. Houmard) and AG-1004 (J. A. Houmard).

Address for reprint requests and other correspondence: C. J. Tanner, Human Performance Laboratory, Ward Sports Medicine Bldg., East Carolina University, Greenville, NC 27858 (TANNERC{at}MAIL.ECU.EDU).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 13 February 2001; accepted in final form 20 August 2001.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Baron, AD. The coupling of glucose metabolism and perfusion in human skeletal muscle: the potential role of endothelium-derived nitric oxide. Diabetes 45, Suppl 1: S105-S109, 1996[ISI][Medline].

2.   Bjornholm, M, Kawano Y, Lehtihet M, and Zierath JR. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 46: 524-527, 1997[Abstract].

3.   Brozinick, JT, Etgen GJ, Yaspelkis BB, Kang HY, and Ivy JL. Effects of exercise training on muscle GLUT-4 protein content and translocation in obese Zucker rats. Am J Physiol Endocrinol Metab 265: E419-E427, 1993[Abstract/Free Full Text].

4.   Burgering, BM, and Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376: 599-562, 1995[ISI][Medline].

5.   Carvalho, CRO, Brenelli SL, Silvia AC, Nunes ALB, Velloso LA, and Saad MJA Effect of aging on insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in liver and muscle of rats. Endocrinology 137: 151-159, 1996[Abstract].

6.   Chibalin, AV, Yu M, Ryder JW, Song XM, Galuska D, Krook A, Walberg-Henriksson H, and Zierath JR. Exercise-induced changes in expression and activity of proteins involved in insulin signal transduction in skeletal muscle: differential effects on insulin-receptor substrates 1 and 2. Proc Natl Acad Sci USA 97: 38-43, 2000[Abstract/Free Full Text].

7.   Cononie, CC, Goldberg AP, Rogus E, and Hagberg JM. Seven consecutive days of exercise lowers plasma insulin responses to an oral glucose challenge in sedentary elderly. J Am Geriatr Soc 42: 394-398, 1994[ISI][Medline].

8.   Cox, JH, Cortright RN, Dohm GL, and Houmard JA. Effect of aging on response to exercise training in humans: skeletal muscle GLUT-4 and insulin sensitivity. J Appl Physiol 86: 2019-2025, 1999[Abstract/Free Full Text].

9.   Cusi, K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanwatr T, DeFronzo RA, Kahn CR, and Manderino LJ. Insulin resistance differentially affects the PI 3-kinase and MAP kinase-mediated signaling in human muscle. J Clin Invest 105: 311-320, 2000[Abstract/Free Full Text].

10.   Czech, MP, and Covera S. Signaling mechanisms that regulate glucose transport. J Biol Chem 274: 1865-1868, 1999[Free Full Text].

11.   DeFronzo, RA. Glucose intolerance and aging. Diabetes Care 4: 493-501, 1981[Abstract].

12.   DeFronzo, RA, Tobin JD, and Andres R. Glucose clamp technique: a method for quantifying secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979[Abstract/Free Full Text].

13.   Feskins, EJM, and Kromhout D. Hyperinsulinemia, risk factors, and coronary heart disease. The Zutphen Elderly Study. Arterioscler Thromb 14: 1641-1647, 1994[Abstract].

14.   Goodyear, LJ, Giorgino F, Balon TW, Condorelli G, and Smith RJ. Effects of contractile activity on tyrosine phosphoproteins and PI 3-kinase activity in rat skeletal muscle. Am J Physiol Endocrinol Metab 268: E987-E995, 1995[Abstract/Free Full Text].

15.   Goodyear, LJ, Giorgino F, Sherman LA, Carey J, Smith RJ, and Dohm GL. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese patients. J Clin Invest 95: 2195-2204, 1995[ISI][Medline].

16.   Goodyear, LJ, and Kahn BB. Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 49: 235-261, 1998[ISI][Medline].

17.   Hickey, MS, Tanner CJ, O'Neill DS, Morgan LJ, Dohm GL, and Houmard JA. Insulin activation of phosphatidylinositol 3-kinase in human skeletal muscle in vivo. J Appl Physiol 83: 718-722, 1997[Abstract/Free Full Text].

18.   Houmard, JH, Egan PC, Neufer PD, Friedman WS, Israel RG, and Dohm GL. Elevated skeletal muscle glucose transporter levels in exercise-trained middle-aged men. Am J Physiol Endocrinol Metab 261: E437-E443, 1991[Abstract/Free Full Text].

19.   Houmard, JA, Shaw CD, Hickey MS, and Tanner CJ. Effect of short-term exercise training on insulin-stimulated PI 3-kinase activity in human skeletal muscle. Am J Physiol Endocrinol Metab 277: E1055-E1060, 1999[Abstract/Free Full Text].

20.   Jackson, RA. Mechanisms of age-related glucose intolerance. Diabetes Care 13, Suppl 2: 9-19, 1990[Abstract].

21.   Jackson, AS, and Pollock ML. Generalized equations for predicting body density of men. Br J Nutr 40: 497-504, 1978[ISI][Medline].

22.   Kahn, CR. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43: 1066-1084, 1994[ISI][Medline].

23.   Kerouz, NJ, Horsch JD, Pons S, and Kahn CR. Differential regulation of insulin receptor substrates-1 and -2 (IRS-1 and IRS-2) and phosphatidylinositol 3-kinase isoforms in liver and muscle of the obese diabetic (ob/ob) mouse. J Clin Invest 100: 3164-3172, 1997[Abstract/Free Full Text].

24.   Kim, Y-B, Nikoulina SE, Ciaraldi TP, Henry RR, and Kahn BB. Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104: 733-741, 1999[Abstract/Free Full Text].

25.   Kim, Y-B, Peroni OD, Franke TF, and Kahn BB. Divergent regulation of Akt1 and Akt2 isoforms in insulin target tissues of obese Zucker rats. Diabetes 49: 847-856, 2000[Abstract].

26.   Kirwan, JP, Del Aguila LF, Hernandez JM, Williamson DL, O'Gorman DJ, Lewis R, and Krishnan RK. Regular exercise enhances insulin activation of IRS-1 associated PI 3-kinase in human skeletal muscle. J Appl Physiol 88: 797-803, 2000[Abstract/Free Full Text].

27.   Kohn, AD, Kovacina KS, and Roth RA. Insulin stimulated the kinase activity of RAC-PK, a pleckstrin homology by domain containing ser/thr kinase. EMBO J 14: 4288-4295, 1995[Abstract].

28.   Krook, A, Roth RA, Jiang XJ, Zierath JR, and Wallberg-Henriksson H. Insulin-stimulated Akt kinase activity is reduced in skeletal muscle from NIDDM subjects. Diabetes 47: 1281-1286, 1998[Abstract].

29.   Leturque, A, Loizeau M, Baulont S, Salminen M, and Girard J. Improvement of insulin action in diabetic transgenic mice selectively overexpressing GLUT4 in skeletal muscle. Diabetes 45: 23-27, 1996[Abstract].

30.   Okamoto, M, Hayashi T, Kono S, Inoue G, Kubota M, Kuzuya H, and Imura H. Specific activity of phosphatidylinositol 3-kinase is increased by insulin stimulation. Biochem J 290: 327-333, 1993[ISI][Medline].

31.   Reaven, GM. Pathophysiology of insulin resistance in human disease. Physiol Rev 75: 473-486, 1995[Abstract/Free Full Text].

32.   Ren, J-M, Marshall BA, Mueckler MM, McCaleb M, Amatruda JM, and Shulman GI. Overexpression of GLUT4 protein in muscle increases basal and insulin-stimulated whole body glucose disposal in conscious mice. J Clin Invest 95: 429-432, 1995[ISI][Medline].

33.   Rogers, MA, Yamamoto C, King DS, Hagberg JM, Ehsani AA, and Holloszy JO. Improvement in glucose tolerance after 1 wk of exercise in patients with mild NIDDM. Diabetes Care 11: 613-618, 1988[Abstract].

34.   Saltiel, AR. Diverse signaling pathways in the cellular actions of insulin. Am J Physiol Endocrinol Metab 270: E375-E385, 1996[Abstract/Free Full Text].

35.   Shepherd, PR, Nave BT, Rincon J, Nolte LA, Bevan AP, Siddle K, Zierath JR, and Wallberg-Henriksson H. Differential regulation of phosphoinositide 3-kinase adapter subunit variants by insulin in human muscle. J Biol Chem 272: 19000-19007, 1997[Abstract/Free Full Text].

36.   Shepherd, PR, Withers DJ, and Siddle K. Phosphoinositide 3-kinase: the key switch in insulin signaling. Biochem J 333: 471-490, 1998[ISI][Medline].

37.   Teruachi, Y, Tsuji Y, Satoh S, Minoura H, Murkami K, Okuno A, Inukai K, Asano T, Kaburagi T, Ueki K, Nakajima H, Hanafusa T, Matsuzawa Y, Sekihara H, Yin Y, Barrett JC, Oda H, Tishikawa Akanuma Y, Komuro I, Suzuki M, Yamamura K, Kodama T, Suzuki H, Koyasu S, Aizawa S, Tobe K, Fukui Y, Yazaki Y, and Kadowaki T. Increased insulin sensitivity and hypoglycemia in mice lacking the p85alpha subunit of phosphoinositide 3-kinase. Nat Genet 21: 230-235, 1999[ISI][Medline].

38.   Tsao, T-S, Burcelin R, Katz EB, and Charron MJ. Enhanced insulin action due to targeted GLUT4 overexpression exclusively in muscle. Diabetes 45: 28-36, 1996[Abstract].

39.   Tsao, T-S, Katz EB, Pommer D, and Charron MJ. Amelioration of insulin resistance but not hyperinsulinemia in obese mice overexpressing GLUT4 selectively in skeletal muscle. Metabolism 49: 340-346, 2000[ISI][Medline].

40.   Wojtaszewski, JFP, Hansen BF, Gade J, Kiens B, Markuns JF, Goodyear LJ, and Richter EA. Insulin signaling and insulin sensitivity after exercise in human skeletal muscle. Diabetes 49: 325-331, 2000[Abstract/Free Full Text].

41.   Wojtaszewski, JFP, Hansen BF, Kiens B, and Richter EA. Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes 46: 1775-1781, 1997[Abstract].


Am J Physiol Endocrinol Metab 282(1):E147-E153
0193-1849/02 $5.00 Copyright © 2002 the American Physiological Society